Sarepta sinks 9% after Elevidys studies placed on hold in Europe
PremiumThe FlySarepta sinks 9% after Elevidys studies placed on hold in Europe
2d ago
Sarepta price target lowered to $183 from $202 at Needham
Premium
The Fly
Sarepta price target lowered to $183 from $202 at Needham
2d ago
Sarepta study pause brings approvability risk in Europe, says RBC
Premium
The Fly
Sarepta study pause brings approvability risk in Europe, says RBC
2d ago
Paramount downgraded, Broadcom upgraded: Wall Street’s top analyst calls
PremiumThe FlyParamount downgraded, Broadcom upgraded: Wall Street’s top analyst calls
3d ago
Sarepta upgraded to Neutral from Sell at H.C. Wainwright
Premium
The Fly
Sarepta upgraded to Neutral from Sell at H.C. Wainwright
3d ago
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Premium
Market News
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
4d ago
Marks resignation ‘not good’ for biotech sector, says RBC
PremiumThe FlyMarks resignation ‘not good’ for biotech sector, says RBC
5d ago
Vaccine, gene therapy makers fall after Peter Marks resignation
Premium
The Fly
Vaccine, gene therapy makers fall after Peter Marks resignation
5d ago
Moderna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns
Premium
Market News
Moderna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns
5d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100